Neuromodulation Devices Market by Technology, Application and Biomaterial Global Opportunity Analysis and Industry Forecast, 2014-2022: KenResearch.com

Neuromodulation Devices Market by Technology (Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation), Application (Chronic Pain Management, Failed back syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s disease, Obsessive-Compulsive Disorder, Migraine) and Biomaterial (Metallic, Polymeric, Ceramic)-Global Opportunity Analysis and Industry Forecast, 2014-2022

No. of pages: 168, No. of Tables: 52, List of figures: 42, Category: Life Sciences, Sub Category: Medical Devices, Author: Deepa Tatkare, Price: USD 4,740

Neuromodulation is the alteration of nerve activity by delivering electrical impulses directly to a target area. Neurological disorders such as epilepsy, Alzheimer disease, cerebrovascular diseases, and Parkinson’s disease affect the central and peripheral nervous system. Bacterial, viral, and fungal infections can also cause neurological disorders. Growth in the Neuromodulation devices market is attributed to increasing prevalence of neurological disorders due to rapidly rising geriatric population, increasing adoption of neuromodulation devices in developed countries, and growing focus of big players, such as Medtronic and Boston Scientific, on R&D in the segment.

The world neuromodulation devices market is estimated to reach USD 11,717 million by 2022. The market is expected to be driven by the increasing awareness about the safety and efficacy of neuromodulation devices, rising prevalence of neurological disorders and rising number of clinical trials worldwide for the development of innovative technologies in the field of neuromodulators. However, lack of trained healthcare professionals and stringent approval policies restrain the market growth.

The world neuromodulation devices market is segmented on the basis of product type, technology, application, material and geography. Based on product type, it is categorized into internal and external neuromodulation. Based on technology, Internal neuromodulation is segmented into five major segments, namely, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators and other neuromodulation devices. Similarly, based on technology external neuromodulation are classified into transcutaneous electrical nerve stimulation and repetitive transcranial magnetic stimulation. Spinal cord stimulators generated the highest revenue in 2015, whereas the deep brain stimulation market is expected to grow fastest by a CAGR of 13.9%. By application, the market is segmented into the following nine segments: failed back syndrome, chronic pain management, epilepsy, tremors, urinary and fecal incontinence, depression, dystonia, gastroparesis, Parkinson’s disease, obsessive-compulsive disorder, migraine, depression and other applications. By biomaterial type, it is divided into metallic biomaterials, ceramic biomaterials and polymeric biomaterials.

Geographically, it is segmented into North America, Europe, Asia-Pacific and LAMEA. Presently, North America occupies the largest market share, followed by Europe and Asia-Pacific. Asia-Pacific is expected to witness maximum growth during the forecast period.

Key strategies adopted by major players include increasing focus on clinical trials for the development of innovative technologies, expanding the indications of the currently marketed neuromodulation devices and mergers &acquisitions. For instance, Boston Scientific is conducting clinical trials oftheir occipital nerve stimulator precision system for chronic migraine. In the year 2015, St. Jude Medical acquired Spinal Modulation Inc. for their AxiumNeurostimulator System.

The report provides comprehensive analyses of the key players operating in the neuromodulation devices market such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc, Nevro Corporation and NeuroPace Inc.

Key Market Benefits

The study provides an in-depth analysis of the world neuromodulation devices market with current trends and future estimations to elucidate the imminent investment pockets.

The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.

Competitive intelligence highlights the business practices followed by leading players across various regions.

SWOT analysis studies the internal environment of the leading companies for strategy formulation.

Key Market Segments

The world neuromodulation devices market is segmented based on technology, applications, material and geography.

By Technology

Internal neuromodulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagus Nerve Stimulation

Spinal Cord Stimulation

Other Neuromodulation Technologies

External neuromodulation

Transcutaneous Electrical Nerve Stimulation

Transcranial Magnetic Stimulation

By Application

Chronic Pain Management

Failed back syndrome

Epilepsy

Tremor

Urinary and Fecal Incontinence

Depression

Dystonia

Gastroparesis

Parkinson’s disease

Obsessive-Compulsive Disorder

Migraine

Other Applications

By Biomaterial

o Metallic Biomaterials

o Polymeric Biomaterials

o Ceramic Biomaterials

By Region

North America

o U.S.

o Canada

o Mexico

Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe

Asia-Pacific

o Japan

o China

o India

o South Korea

o Malaysia

o Rest of Asia-Pacific

LAMEA

o Brazil

o Israel

o South Africa

o Saudi Arabia

o Rest of LAMEA

Source:https://www.kenresearch.com/metal-mining-and-chemicals/chemicals/neuromodulation-devices-market-technology/48776-101.html